Sign in to comment!

Menu
Home

U.S.

Drugmaker Ranbaxy halts production of generic Lipitor following recall over glass in bottles

Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles got into dozens of batches of the drug that were recalled in November.

The Food and Drug Administration says Ranbaxy won't resume manufacturing generic Lipitor, or atorvastatin, until it determines the problem's cause and fixes it.

The problem-plagued drugmaker, a subsidiary of India's Ranbaxy Laboratories Ltd., since last December has been operating under increased FDA scrutiny because of quality lapses at multiple factories over several years.

The recall covered 41 batches of 10-, 20- and 40-milligram doses of atorvastatin tablets.

A Ranbaxy spokesman did not immediately respond to messages from The Associated Press Friday.

Several other companies also make generic versions of Lipitor, which was the world's top-selling drug for years.

Bank Rates

Loan Type Graph Rate +/- Last Week
30 Y Fixed Graph 3.96% dw 3.98%  
15 Y Fixed Graph 3.07% dw 3.09%  
30 Y Fixed Jumbo Graph 4.17% dw 4.18%  
5/1 ARM Graph 3.20% dw 3.23%  
5/1 Jumbo ARM Graph 3.48% up 3.47%  
Loan Type Graph Rate +/- Last Week
$30K HELOC Graph 4.32% up 4.29%  
$50K HELOC Graph 3.98% up 3.96%  
$30K Loan Graph 4.99% -- 4.99%  
$50K Loan Graph 4.34% -- 4.34%  
$75K Loan Graph 4.36% -- 4.36%  
Loan Type Graph Rate +/- Last Week
36 M New Graph 2.93% dw 2.94%  
36 M Used Graph 3.47% dw 3.48%  
48 M New Graph 3.18% dw 3.22%  
48 M Used Graph 2.99% dw 3.05%  
60 M New Graph 3.19% dw 3.24%  
Loan Type Graph Yield +/- Last Week
6 month Graph 0.39% -- 0.39%  
1 yr Graph 0.70% -- 0.70%  
5 yr Graph 1.55% -- 1.55%